Literature DB >> 22222765

Nicotine persistently activates ventral tegmental area dopaminergic neurons via nicotinic acetylcholine receptors containing α4 and α6 subunits.

Liwang Liu1, Rubing Zhao-Shea, J Michael McIntosh, Paul D Gardner, Andrew R Tapper.   

Abstract

Nicotine is reinforcing because it activates dopaminergic (DAergic) neurons within the ventral tegmental area (VTA) of the brain's mesocorticolimbic reward circuitry. This increase in activity can occur for a period of several minutes up to an hour and is thought to be a critical component of nicotine dependence. However, nicotine concentrations that are routinely self-administered by smokers are predicted to desensitize high-affinity α4β2 neuronal nicotinic acetylcholine receptors (nAChRs) in seconds. Thus, how physiologically relevant nicotine concentrations persistently activate VTA DAergic neurons is unknown. Here we show that nicotine can directly and robustly increase the firing frequency of VTA DAergic neurons for several minutes. In mouse midbrain slices, 300 nM nicotine elicited a persistent inward current in VTA DAergic neurons that was blocked by α-conotoxin MII[H9A;L15A], a selective antagonist of nAChRs containing the α6 subunit. α-conotoxin MII[H9A;L15A] also significantly reduced the long-lasting increase in DAergic neuronal activity produced by low concentrations of nicotine. In addition, nicotine failed to significantly activate VTA DAergic neurons in mice that did not express either α4 or α6 nAChR subunits. Conversely, selective activation of nAChRs containing the α4 subunit in knock-in mice expressing a hypersensitive version of these receptors yielded a biphasic response to nicotine consisting of an acute desensitizing increase in firing frequency followed by a sustained increase that lasted several minutes and was sensitive to α-conotoxin MII[H9A;L15A]. These data indicate that nicotine persistently activates VTA DAergic neurons via nAChRs containing α4 and α6 subunits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222765      PMCID: PMC3310415          DOI: 10.1124/mol.111.076661

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.

Authors:  Craig D C Bailey; Mariella De Biasi; Paul J Fletcher; Evelyn K Lambe
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

2.  Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.

Authors:  Rubing Zhao-Shea; Liwang Liu; Lindsey G Soll; Ma Reina Improgo; Erin E Meyers; J Michael McIntosh; Sharon R Grady; Michael J Marks; Paul D Gardner; Andrew R Tapper
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.

Authors:  Cecilia Gotti; Stefania Guiducci; Vincenzo Tedesco; Silvia Corbioli; Lara Zanetti; Milena Moretti; Alessio Zanardi; Roberto Rimondini; Manolo Mugnaini; Francesco Clementi; Christian Chiamulera; Michele Zoli
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

4.  Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

Authors:  H D Mansvelder; D S McGehee
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

5.  Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine.

Authors:  Richard Exley; Nicolas Maubourguet; Vincent David; Raphaël Eddine; Alexis Evrard; Stéphanie Pons; Fabio Marti; Sarah Threlfell; Pierre Cazala; J Michael McIntosh; Jean-Pierre Changeux; Uwe Maskos; Stephanie J Cragg; Philippe Faure
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

6.  Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse.

Authors:  S A Ross; J Y Wong; J J Clifford; A Kinsella; J S Massalas; M K Horne; I E Scheffer; I Kola; J L Waddington; S F Berkovic; J Drago
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

Review 7.  Reward, addiction, withdrawal to nicotine.

Authors:  Mariella De Biasi; John A Dani
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

8.  Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-09-10       Impact factor: 17.586

Review 9.  Nicotinic mechanisms influencing synaptic plasticity in the hippocampus.

Authors:  Andon Nicholas Placzek; Tao A Zhang; John Anthony Dani
Journal:  Acta Pharmacol Sin       Date:  2009-05-11       Impact factor: 6.150

10.  Nicotinic activation of laterodorsal tegmental neurons: implications for addiction to nicotine.

Authors:  Masaru Ishibashi; Christopher S Leonard; Kristi A Kohlmeier
Journal:  Neuropsychopharmacology       Date:  2009-07-22       Impact factor: 7.853

View more
  55 in total

1.  Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Authors:  Xiomara A Perez; J Michael McIntosh; Maryka Quik
Journal:  J Neurochem       Date:  2013-10-13       Impact factor: 5.372

2.  Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.

Authors:  Maryka Quik; Carla Campos; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

3.  Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Miguel Ruiz; Mick'l Scadden; Sean Christensen; Joanna Gajewiak; Layla Azam; J Michael McIntosh
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

4.  Why flavored vape products may be attractive: Green apple tobacco flavor elicits reward-related behavior, upregulates nAChRs on VTA dopamine neurons, and alters midbrain dopamine and GABA neuron function.

Authors:  Alicia J Avelar; Austin T Akers; Zachary J Baumgard; Skylar Y Cooper; Gabriella P Casinelli; Brandon J Henderson
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

5.  Nicotinic acetylcholine receptors containing the α4 subunit modulate alcohol reward.

Authors:  Liwang Liu; Linzy M Hendrickson; Melissa J Guildford; Rubing Zhao-Shea; Paul D Gardner; Andrew R Tapper
Journal:  Biol Psychiatry       Date:  2012-11-09       Impact factor: 13.382

6.  α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Mick'l Scadden; Joanna Gajewiak; Sean Christensen; Jon Lindstrom; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

Review 7.  Neuronal Nicotinic Acetylcholine Receptor Structure and Function and Response to Nicotine.

Authors:  John A Dani
Journal:  Int Rev Neurobiol       Date:  2015-08-21       Impact factor: 3.230

8.  Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors.

Authors:  Staci E Engle; J Michael McIntosh; Ryan M Drenan
Journal:  Neuropharmacology       Date:  2014-12-04       Impact factor: 5.250

Review 9.  Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations.

Authors:  Ryan M Drenan; Henry A Lester
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

10.  Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours.

Authors:  M S Powers; H J Broderick; R M Drenan; J A Chester
Journal:  Genes Brain Behav       Date:  2013-05-07       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.